TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹3,364 Cr |
| Mar2024 | ₹2,824 Cr |
| Mar2023 | ₹2,431 Cr |
| Mar2022 | ₹2,480 Cr |
| Mar2021 | ₹2,170 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,364 Cr | 19.11 | |
| Mar2024 | ₹2,824 Cr | 16.15 | |
| Mar2023 | ₹2,431 Cr | -1.97 | |
| Mar2022 | ₹2,480 Cr | 14.27 | |
| Mar2021 | ₹2,170 Cr | - | |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹139,278.7 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
| MANKIND PHARMA | ₹93,582.0 Cr | 5.8% | 13.4% | -11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.7% |
-3.6% |
27.4% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses